Roche Stock Forecast, Price & News

Roche (OTCMKTS:RHHBY) Frequently Asked Questions

Is Roche a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Roche stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RHHBY, but not buy additional shares or sell existing shares.
View analyst ratings for Roche or view top-rated stocks.

What stocks does MarketBeat like better than Roche?

Wall Street analysts have given Roche a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Roche wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Roche?

Roche saw a increase in short interest in the month of August. As of August 13th, there was short interest totaling 1,174,900 shares, an increase of 54.6% from the July 29th total of 759,900 shares. Based on an average trading volume of 2,032,900 shares, the short-interest ratio is presently 0.6 days.
View Roche's Short Interest.

How has Roche's stock price been impacted by Coronavirus?

Roche's stock was trading at $40.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RHHBY stock has increased by 12.5% and is now trading at $46.01.
View which stocks have been most impacted by COVID-19.

How often does Roche pay dividends? What is the dividend yield for Roche?

Roche declared a dividend on Friday, March 5th. Investors of record on Friday, March 19th will be paid a dividend of $1.2782 per share on Monday, March 29th. This represents a dividend yield of 3.11%. The ex-dividend date of this dividend is Thursday, March 18th.
View Roche's dividend history.

Is Roche a good dividend stock?

Roche pays an annual dividend of $0.77 per share and currently has a dividend yield of 1.66%. The dividend payout ratio of Roche is 29.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Roche will have a dividend payout ratio of 27.50% next year. This indicates that Roche will be able to sustain or increase its dividend.
View Roche's dividend history.

What price target have analysts set for RHHBY?

11 brokers have issued 1 year price targets for Roche's stock. Their forecasts range from $46.42 to $46.42. On average, they expect Roche's stock price to reach $46.42 in the next twelve months. This suggests a possible upside of 0.9% from the stock's current price.
View analysts' price targets for Roche or view top-rated stocks among Wall Street analysts.

Who are Roche's key executives?

Roche's management team includes the following people:

• Severin Schwan, Chief Executive Officer & Executive Director
• Alan Hippe, Chief Financial & Information Technology Officer
• Urs Jaisli, Chief Compliance Officer
• Per-Olof Attinger, Secretary-Executive Committee & Head-CEO Office
• William Pao, Head-Pharma Research & Early Development

Who are some of Roche's key competitors?

Some companies that are related to Roche include Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk A/S (NVO), Eli Lilly and (LLY), Abbott Laboratories (ABT), AbbVie (ABBV), AstraZeneca (AZN), Merck & Co., Inc. (MRK), Novartis (NVS), Bristol-Myers Squibb (BMY), Sanofi (SNY), GlaxoSmithKline (GSK), CSL (CSLLY), Zoetis (ZTS) and Regeneron Pharmaceuticals (REGN).
View all of RHHBY's competitors.

What is Roche's stock symbol?

Roche trades on the OTCMKTS under the ticker symbol "RHHBY."

Who are Roche's major shareholders?

Roche's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Parametric Portfolio Associates LLC (0.09%), ARK Investment Management LLC (0.07%), Fisher Asset Management LLC (0.04%), Saratoga Research & Investment Management (0.02%), Cullen Capital Management LLC (0.02%) and Bristol John W & Co. Inc. NY (0.00%).

Which institutional investors are selling Roche stock?

RHHBY stock was sold by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Douglass Winthrop Advisors LLC, Kornitzer Capital Management Inc. KS, Page Arthur B, Tocqueville Asset Management L.P., Wendell David Associates Inc., Fairfield Bush & CO., and Oak Associates Ltd. OH.

Which institutional investors are buying Roche stock?

RHHBY stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Bristol John W & Co. Inc. NY, Saratoga Research & Investment Management, Parametric Portfolio Associates LLC, Oxbow Advisors LLC, Cullen Capital Management LLC, Boston Common Asset Management LLC, and FCA Corp TX.

How do I buy shares of Roche?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Roche's stock price today?

One share of RHHBY stock can currently be purchased for approximately $46.01.

How much money does Roche make?

Roche has a market capitalization of $314.25 billion and generates $64.54 billion in revenue each year. The company earns $15.25 billion in net income (profit) each year or $2.65 on an earnings per share basis.

How many employees does Roche have?

Roche employs 101,465 workers across the globe.

Does Roche have any subsidiaries?

The following companies are subsidiares of Roche: 454 Life Sciences, Adheron Therapeutics, Adheron Therapeutics Inc., Anadys Pharmaceuticals, Anadys Pharmaceuticals Inc., Ariosa Diagnostics, Ariosa Diagnostics Inc., Arius Research, Ascur Versicherungsvermittlungs GmbH, BINA Technology, Bina Technologies Inc., BioImagene, BioVeris, BioVeris Corporation, Biopharm AG, Boehringer Mannheim, Borean Pharma, Chemical Manufacturing and Trading Company Limited, Chugai Pharmaceutical Co. Ltd., Disetronic Holding AG, Dutalys GmbH, F. Hoffmann-La Roche Ltd, F. Hoffmann-La Roche Ltd / Jordan P.S.C., FLLC "Roche Products Limited", FMI Germany GmbH, Flatiron Health, Flatiron Health Inc., ForSight Labs, ForSight VISION4 Inc., Foundation Medicine, Foundation Medicine Inc., Foundation Medicine Securities Corporation, Galenus Mannheim Pharma GmbH, GeneWEAVE, GeneWEAVE Biosciences Inc., Genentech, Genentech Inc., Genentech P.R. Inc., Genentech USA Inc., Genia Technologies, Hoffmann - La Roche Ltd, Hoffmann-La Roche Inc., Hoffmann-La Roche Limited, Hoffmann-La Roche Products Limited, I5 Surviving Corp., IGEN International Inc., IGEN LS LLC, IQuum, IQuum Inc., Ignyta, Ignyta Inc., Inflazome, Infogenetik Moleküler Bilgi Hizmetleri Anonim Sirketi, Institut Roche SAS, InterMune, InterMune Holdings Limited, InterMune Inc., InterMune International AG, Jecure Therapeutics Inc., Kapa Biosystems, Kapa Biosystems (Pty) Ltd, Kapa Biosystems Inc., Limited Liability Company Roche Diabetes Care Rus, Limited Liability Company Roche Diagnostics Rus, MTM Laboratories, Marcadia Biotech, Medingo Ltd., Medingo Medical Solutions, Memory Pharmaceuticals, Memory Pharmaceuticals Corp., Mirus, Museum Tinguely AG, N.V. Roche S.A., P.T. Roche Indonesia, PVT Probenverteiltechnik GmbH, Phaor AG, Piramed, Productos Roche (El Salvador) S.A. de C.V., Productos Roche (Honduras) S.A., Productos Roche (Nicaragua) S.A., Productos Roche (Panama) S.A., Productos Roche Dominicana S.R.L., Productos Roche Guatemala (Sociedad Anónima), Productos Roche Interamericana S.A. (PRISA), Productos Roche Química Farmacéutica S.A., Productos Roche S.A., Productos Roche S.A. Química e Industrial, Productos Roche S.A. de C.V., Produtos Roche Químicos e Farmacêuticos S.A., Promedior, Rabbit-Air Ltd, RoDiagnostics Egypt for Trading S.A.E, Roche (China) Holding Ltd., Roche (Hellas) S.A., Roche (Hungary) Ltd, Roche (Malaysia) Sdn. Bhd., Roche (Philippines) Inc., Roche (Shanghai) Pharmaceuticals Consulting Co. Ltd, Roche (Shanghai) Pharmaceuticals Trading Co. Ltd., Roche - Moscow Ltd., Roche AB, Roche Algérie SPA, Roche Austria GmbH, Roche Bangladesh Limited, Roche Beteiligungs GmbH, Roche Biomedical Laboratories Inc., Roche Bolivia SRL., Roche Bulgaria EOOD, Roche Cameroun SARL, Roche Capital Market Ltd, Roche Capital Services Ltd., Roche Catalyst Investments Ltd., Roche Chemische Unternehmungen AG, Roche Chile Limitada, Roche Côte d’Ivoire SARL, Roche DC Japan K. K., Roche DC México S.A. de C.V., Roche Deutschland Holding GmbH, Roche Diabetes Care (Switzerland) Ltd, Roche Diabetes Care Argentina S.A., Roche Diabetes Care Asia Pacific Pte. Ltd., Roche Diabetes Care Australia Pty Limited, Roche Diabetes Care Austria GmbH, Roche Diabetes Care Brasil Ltda., Roche Diabetes Care Deutschland GmbH, Roche Diabetes Care France SAS, Roche Diabetes Care GmbH, Roche Diabetes Care Inc., Roche Diabetes Care India Private Limited, Roche Diabetes Care Italy S.p.A., Roche Diabetes Care Limited, Roche Diabetes Care Middle East FZCO, Roche Diabetes Care Nederland B.V., Roche Diabetes Care Polska sp. z o.o., Roche Diabetes Care South Africa Proprietary Limited, Roche Diabetes Care Spain S.L., Roche Diagnostica Brasil Ltda., Roche Diagnostics (Hellas) S.A., Roche Diagnostics (Hong Kong) Limited, Roche Diagnostics (Malaysia) Sdn. Bhd., Roche Diagnostics (Shanghai) Ltd., Roche Diagnostics (Suzhou) Limited, Roche Diagnostics (Switzerland) Ltd, Roche Diagnostics (Thailand) Limited, Roche Diagnostics Asia Pacific Pte. Ltd., Roche Diagnostics Australia Pty. Limited, Roche Diagnostics Belgium NV, Roche Diagnostics Corporation, Roche Diagnostics Deutschland GmbH, Roche Diagnostics France SAS, Roche Diagnostics GmbH, Roche Diagnostics Hematology Inc., Roche Diagnostics India Private Limited, Roche Diagnostics International Ltd, Roche Diagnostics K.K., Roche Diagnostics Korea Co. Ltd., Roche Diagnostics Limited, Roche Diagnostics Ltd., Roche Diagnostics Middle East FZCO, Roche Diagnostics NZ Limited, Roche Diagnostics Nederland B.V., Roche Diagnostics Norge A/S, Roche Diagnostics Operations Inc., Roche Diagnostics Oy, Roche Diagnostics Polska Sp. z o.o., Roche Diagnostics Proprietary Limited, Roche Diagnostics S.L., Roche Diagnostics S.p.A., Roche Diagnostics Scandinavia AB, Roche Diagnostics Turkey Anonim Sirketi, Roche Diagnostics a/s, Roche Ecuador S.A., Roche Eesti OÜ, Roche Egypt LLC, Roche Egypt for Manufacturing and Trading SAE, Roche Farma (Peru) S.A., Roche Farma S.A., Roche Farmacêutica Química Lda., Roche Finance Europe B.V., Roche Finance Ltd, Roche Financial Investments Ltd., Roche Financial Management Ltd., Roche Financial Services Ltd., Roche Forum Buonas Ltd, Roche Georgia LLC, Roche Glycart, Roche Glycart Ltd, Roche Health Solutions Inc., Roche Holding (UK) Limited, Roche Holdings Inc., Roche Hong Kong Limited, Roche Innovation Center Copenhagen A/S, Roche Innovatis, Roche International Ltd., Roche International Ltd. (Montevideo Branch), Roche Intertrade Limited, Roche Ireland Limited, Roche Kazakhstan LLP, Roche Kenya Limited, Roche Korea Company Ltd., Roche Laboratories Inc., Roche Latvija SIA, Roche Lebanon S.A.R.L., Roche Long Term Foundation, Roche Makedonija DOOEL, Roche Molecular Systems Inc., Roche Myanmar Company Limited, Roche Müstahzarlari Sanayi Anonim Sirketi, Roche Nederland B.V., Roche NimbleGen, Roche Norge A/S, Roche Operations Ltd., Roche Oy, Roche PVT GmbH, Roche Pakistan Limited, Roche Palo Alto LLC, Roche Pars Co. (Ltd.), Roche Pharma (Switzerland) Ltd, Roche Pharma AG, Roche Pharmaceuticals (Israel) Ltd., Roche Pharmaceuticals Middle East FZCO, Roche Pharmholding B.V., Roche Polska Sp. z o.o., Roche Privacy GmbH, Roche Products (India) Private Limited, Roche Products (Ireland) Limited, Roche Products (Mauritius) Ltd, Roche Products (New Zealand) Limited, Roche Products (Proprietary) Limited, Roche Products Ghana Limited, Roche Products Inc., Roche Products Limited, Roche Products Ltd., Roche Products Pty. Limited, Roche Products Saudi Arabia LLC, Roche R&D Center (China) Ltd., Roche Real Estate Services Mannheim GmbH, Roche Registration GmbH, Roche Registration Limited, Roche Romania S.R.L., Roche S.A., Roche S.p.A., Roche SAS, Roche Sequencing Solutions Inc., Roche Services (Asia Pacific) Sdn. Bhd., Roche Services (Europe) Ltd, Roche Services Americas Sociedad de Responsabilidad Limitada, Roche Services Holdings Ltd., Roche Servicios S.A., Roche Servicios de México S.A. de C.V., Roche Singapore Pte. Ltd., Roche Singapore Technical Operations Pte. Ltd., Roche Sistemas de Diagnósticos Sociedade Unipessoal Lda., Roche Slovensko S.R.O., Roche TCRC Inc., Roche Thailand Limited, Roche Tunisie SA, Roche Ukraine LLC, Roche Vietnam Company Limited, Roche a/s Medicinalvarer og Kemikalier, Roche d.o.o., Roche d.o.o. farmaceutsko drustvo – Roche Ltd. Pharmaceutical Company, Roche farmacevtska družba d.o.o., Roche mtm laboratories AG, Roche s.r.o., Santaris Pharma, Sapac Corporation Ltd., Seragon Pharmaceuticals Inc., Shanghai Roche Pharmaceuticals Limited, Signature Diagnostics GmbH, Spark Therapeutics, Spring Bioscience Corp., Stratos Genomics, Syntex Corporation, Syntex Pharm AG, Syntex Pharmaceuticals International Limited, Syntex Puerto Rico Inc., Tanox Inc., Tavero AG, Tensha Therapeutics, Tensha Therapeutics Inc., Therapeutic Human Polyclonals, Therapeutic Human Polyclonals Inc., Trophos, Trophos SA, Tusk Therapeutics, Tusk Therapeutics Limited, UAB Roche Lietuva, Ventana Medical Systems, Ventana Medical Systems Inc., Verum Diagnostica GmbH, Viewics, Viewics Inc., Viewics India Private Limited, mySugr, mySugr GmbH, and mySugr Inc..

When was Roche founded?

Roche was founded in 1896.

What is Roche's official website?

The official website for Roche is www.roche.com.

Where are Roche's headquarters?

Roche is headquartered at GRENZACHERSTRASSE 124, BASEL V8, CH-4070.

How can I contact Roche?

Roche's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at (161) 688-1111 or via email at [email protected].